|
JPS59186924A
(ja)
|
1983-04-08 |
1984-10-23 |
Kureha Chem Ind Co Ltd |
ヒト免疫グロブリン結合抗腫瘍剤
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5395855A
(en)
|
1990-05-07 |
1995-03-07 |
Ciba-Geigy Corporation |
Hydrazones
|
|
US5484612A
(en)
|
1993-09-22 |
1996-01-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
|
|
US6011069A
(en)
|
1995-12-26 |
2000-01-04 |
Nisshin Flour Milling Co., Ltd. |
Multidrug resistance inhibitors
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
AU3276297A
(en)
|
1996-06-27 |
1998-01-14 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for myeloma to be used together with nitrogen mustard antitumor agents
|
|
US6121245A
(en)
|
1997-01-29 |
2000-09-19 |
Firshein; Richard N. |
Method of treating cancer using alkylglycerols in conjunction with chemotherapy
|
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
|
US20040072889A1
(en)
|
1997-04-21 |
2004-04-15 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
|
|
EA200000087A1
(ru)
|
1997-07-01 |
2000-08-28 |
Атеродженикс, Инк. |
Повышение эффективности терапии гиперпролиферативных состояний с помощью антиоксиданта
|
|
GB9721069D0
(en)
|
1997-10-03 |
1997-12-03 |
Pharmacia & Upjohn Spa |
Polymeric derivatives of camptothecin
|
|
US6100254A
(en)
|
1997-10-10 |
2000-08-08 |
Board Of Regents, The University Of Texas System |
Inhibitors of protein tyrosine kinases
|
|
US6288234B1
(en)
|
1998-06-08 |
2001-09-11 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
EP1104297B8
(en)
|
1998-07-09 |
2006-05-03 |
Cephalon, Inc. |
Compositions for the treatment of chronic lymphocytic leukemia
|
|
BR9912938B1
(pt)
|
1998-08-11 |
2011-06-28 |
|
derivados de isoquinolina, composição que os compreende, processo para preparação e uso dos mesmos.
|
|
US6326390B1
(en)
|
1998-08-25 |
2001-12-04 |
King Pharmaceuticals Reseach And Development, Inc. |
Use of adenosine A3 receptor antagonists to inhibit tumor growth
|
|
PT1165085E
(pt)
|
1999-03-30 |
2006-10-31 |
Novartis Ag |
Derivados de ftalazina para tratar doencas inflamatorias
|
|
WO2008109417A1
(en)
|
2007-03-02 |
2008-09-12 |
Case Western Reserve University |
Mgmt inhibitor combinations for the treatment of neoplastic disorders
|
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
|
AR030557A1
(es)
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
|
EP1160826A3
(en)
|
2000-05-30 |
2006-12-13 |
Ebara Corporation |
Coating, modification and etching of substrate surface with particle beam irradiation
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
US6613736B2
(en)
|
2000-06-16 |
2003-09-02 |
Thomas T. Aoki |
System and method for treating eye and nerve diseases in diabetic and non-diabetic patients
|
|
JP5000831B2
(ja)
|
2000-06-23 |
2012-08-15 |
田辺三菱製薬株式会社 |
抗腫瘍作用増強剤
|
|
US7473691B2
(en)
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
JP2004509115A
(ja)
|
2000-09-15 |
2004-03-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターとして有用なピラゾール化合物
|
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6610677B2
(en)
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
CN1116875C
(zh)
|
2000-10-19 |
2003-08-06 |
南京振中生物工程有限公司 |
紫杉醇脂质组合物及其制备方法
|
|
US6503914B1
(en)
|
2000-10-23 |
2003-01-07 |
Board Of Regents, The University Of Texas System |
Thienopyrimidine-based inhibitors of the Src family
|
|
HU230875B1
(hu)
|
2000-10-30 |
2018-11-29 |
Euro-Celtique S.A. |
Szabályozott hatóanyag-leadású hidrokodon készítmények
|
|
US7619005B2
(en)
|
2000-11-01 |
2009-11-17 |
Cognition Pharmaceuticals Llc |
Methods for treating cognitive impairment in humans with Multiple Sclerosis
|
|
US20020155565A1
(en)
|
2000-11-10 |
2002-10-24 |
Pilar Garin-Chesa |
FAP-activated anti-tumor compounds
|
|
PT1355905E
(pt)
|
2000-12-21 |
2007-05-31 |
Vertex Pharma |
Compostos de pirazole úteis como inibidores de proteínaquinase
|
|
US20100098691A1
(en)
|
2001-01-24 |
2010-04-22 |
S'bio Pte Ltd |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
|
IL159048A0
(en)
|
2001-06-21 |
2004-05-12 |
Genentech Inc |
Sustained release formulation
|
|
US7005445B2
(en)
|
2001-10-22 |
2006-02-28 |
The Research Foundation Of State University Of New York |
Protein kinase and phosphatase inhibitors and methods for designing them
|
|
US20030158118A1
(en)
|
2001-11-26 |
2003-08-21 |
Weidner Morten Sloth |
Combination of cimetidine and cysteine derivatives for treating cancer
|
|
UA76810C2
(uk)
|
2001-12-10 |
2006-09-15 |
Мерк Енд Ко., Інк. |
Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
|
|
US7045534B2
(en)
|
2002-02-12 |
2006-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of reducing angiogenesis
|
|
AU2003219796A1
(en)
|
2002-02-20 |
2003-09-09 |
Beth Israel Deaconess Medical Center |
Conjugates comprising a biodegradable polymer and uses therefor
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
US7112676B2
(en)
|
2002-11-04 |
2006-09-26 |
Hoffmann-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
|
TW200413381A
(en)
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
|
EP2314691A3
(en)
|
2002-11-14 |
2012-01-18 |
Dharmacon, Inc. |
Fuctional and hyperfunctional siRNA
|
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
|
US7276519B2
(en)
|
2002-11-25 |
2007-10-02 |
Wyeth |
Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
|
|
JP5269281B2
(ja)
|
2002-12-30 |
2013-08-21 |
セルジーン コーポレイション |
フルオロアルコキシ置換１，３−ジヒドロイソインドリル化合物およびそれらの医薬としての使用
|
|
CN103265477B
(zh)
|
2003-02-26 |
2017-01-11 |
苏根公司 |
作为蛋白激酶抑制剂的氨基杂芳基化合物
|
|
JP2006521361A
(ja)
|
2003-03-24 |
2006-09-21 |
セコイア、ファーマシューティカルズ、インコーポレイテッド |
長時間作用生物活性コンジュゲート
|
|
TW200502236A
(en)
|
2003-03-28 |
2005-01-16 |
Hoffmann La Roche |
Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
|
|
US7220706B1
(en)
|
2003-05-14 |
2007-05-22 |
Praxair S.T. Technology, Inc. |
Enhanced melt-textured growth
|
|
US7385055B2
(en)
|
2003-05-19 |
2008-06-10 |
Board Of Trustees Of Michigan State University |
Preparation of hymenialdisine derivatives and use thereof
|
|
US7842835B2
(en)
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
US20050009891A1
(en)
|
2003-07-09 |
2005-01-13 |
Lee Francis Y. |
Combination of SRC Kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
|
|
WO2005013982A1
(en)
|
2003-08-06 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
|
WO2005014577A1
(en)
|
2003-08-07 |
2005-02-17 |
Schering Corporation |
Novel farnesyl protein transferase inhibitors as antitumor agents
|
|
TW200524940A
(en)
|
2003-10-02 |
2005-08-01 |
Salmedix Inc |
Indole derivatives
|
|
HUP0303313A2
(hu)
|
2003-10-09 |
2005-07-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
Transzdermális gyógyszerkészítmények
|
|
US7169781B2
(en)
|
2003-10-17 |
2007-01-30 |
Hoffmann-La Roche Inc. |
Imidazole derivatives and their use as pharmaceutical agents
|
|
SG146681A1
(en)
|
2003-11-06 |
2008-10-30 |
Wyeth Corp |
4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
|
|
US7491725B2
(en)
|
2004-02-06 |
2009-02-17 |
Bristol-Myers Squibb Company |
Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
|
|
WO2005080392A1
(ja)
|
2004-02-19 |
2005-09-01 |
Takeda Pharmaceutical Company Limited |
ピラゾロキノロン誘導体およびその用途
|
|
WO2005090344A1
(en)
|
2004-03-15 |
2005-09-29 |
F. Hoffmann-La Roche Ag |
Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
|
|
US7910621B2
(en)
|
2004-03-22 |
2011-03-22 |
The Regents Of The University Of Michigan |
Small molecule antagonists of XIAP family proteins
|
|
CA2561617A1
(en)
|
2004-04-05 |
2005-10-20 |
Aton Pharma, Inc. |
Histone deacetylase inhibitor prodrugs
|
|
TW200538149A
(en)
|
2004-05-20 |
2005-12-01 |
Telik Inc |
Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
|
|
TW200600091A
(en)
|
2004-05-21 |
2006-01-01 |
Telik Inc |
Sulfonylethyl phosphorodiamidates
|
|
EP1771474B1
(en)
|
2004-07-20 |
2010-01-27 |
Genentech, Inc. |
Inhibitors of angiopoietin-like 4 protein, combinations, and their use
|
|
SE0402025D0
(sv)
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
|
US7479561B2
(en)
|
2004-08-16 |
2009-01-20 |
Wyeth |
4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors
|
|
KR100853974B1
(ko)
|
2004-08-31 |
2008-08-25 |
에프. 호프만-라 로슈 아게 |
7-아미노-3-페닐 디히드로피리미도[4,5-ｄ]피리미디논의아미드 유도체, 그의 제조 방법 및 약학제로서의 용도
|
|
WO2006031806A2
(en)
|
2004-09-10 |
2006-03-23 |
Atherogenics, Inc. |
2-thiopyrimidinones as therapeutic agents
|
|
CA2579406A1
(en)
|
2004-09-21 |
2006-03-30 |
F.Hoffmann-La Roche Ag |
6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as protein kinase inhibitors
|
|
US7355677B2
(en)
|
2004-12-09 |
2008-04-08 |
Asml Netherlands B.V. |
System and method for an improved illumination system in a lithographic apparatus
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
CA2589877A1
(en)
|
2004-12-23 |
2006-06-29 |
F. Hoffmann-La Roche Ag |
Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors
|
|
CN101087787A
(zh)
|
2004-12-23 |
2007-12-12 |
霍夫曼-拉罗奇有限公司 |
苯甲酰胺衍生物，它们的制备及作为药剂的应用
|
|
US7968574B2
(en)
|
2004-12-28 |
2011-06-28 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
|
EP1919882A2
(en)
|
2005-02-17 |
2008-05-14 |
Synta Pharmaceuticals Corporation |
Isoxazole combretastatin derivatives for the treatment of proliferative disorders
|
|
US20060229277A1
(en)
|
2005-04-08 |
2006-10-12 |
Orbus Pharma, Inc. |
Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
|
|
US8242103B2
(en)
|
2005-05-19 |
2012-08-14 |
Merck Sharp & Dohme Limited |
Sulphamides for treatment of cancer
|
|
NZ563686A
(en)
|
2005-06-07 |
2011-07-29 |
Univ Yale |
Methods of treating cancer and other conditions or disease states using LFMAU and LDT
|
|
MX346530B
(es)
|
2005-06-15 |
2017-03-22 |
Cardiome Pharma Corp |
Procedimiento sintético para la preparación de compuestos de éter aminociclohexílico.
|
|
US8207186B2
(en)
|
2005-06-23 |
2012-06-26 |
Merck Sharp & Dohme Corp. |
Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET
|
|
PT3248613T
(pt)
|
2005-07-18 |
2022-03-16 |
Seagen Inc |
Conjugados de ligante de fármaco e beta-glucuronida
|
|
US7776878B2
(en)
|
2005-08-01 |
2010-08-17 |
Hoffmann-La Roche Inc. |
Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents
|
|
WO2007032936A2
(en)
|
2005-09-09 |
2007-03-22 |
Schering Corporation |
Azafused cyclin dependent kinase inhibitors
|
|
WO2007069272A2
(en)
|
2005-10-21 |
2007-06-21 |
Panacea Biotec Limited |
Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
|
|
JP5191391B2
(ja)
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
NZ594385A
(en)
|
2005-11-03 |
2013-02-22 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
|
AU2006322314A1
(en)
|
2005-11-18 |
2007-06-14 |
Synthon B.V. |
Zolpidem tablets
|
|
UA116187C2
(uk)
|
2005-12-13 |
2018-02-26 |
Інсайт Холдінгс Корпорейшн |
ГЕТЕРОАРИЛЗАМІЩЕНІ ПІРОЛО[2,3-b]ПІРИДИНИ Й ПІРОЛО[2,3-b]ПІРИМІДИНИ ЯК ІНГІБІТОРИ ЯНУС-КІНАЗИ
|
|
US8014957B2
(en)
*
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
|
WO2007081751A2
(en)
|
2006-01-05 |
2007-07-19 |
The Johns Hopkins University |
Compositions and methods for the treatment of cancer
|
|
ATE439361T1
(de)
|
2006-01-31 |
2009-08-15 |
Hoffmann La Roche |
7h-pyridoä3,4-düpyrimidin-8-one, ihre herstellung und ihre verwendung als proteinkinaseinhibitoren
|
|
JP5220724B2
(ja)
|
2006-03-14 |
2013-06-26 |
ニューレン ファーマシューティカルズ リミテッド |
グリシル−２−メチルプロリルグルタミン酸塩の経口製剤
|
|
CA2644369A1
(en)
|
2006-03-28 |
2007-10-04 |
Novartis Ag |
Amide derivatives and their application for the treatment of g protein related diseases
|
|
KR20140019032A
(ko)
|
2006-04-05 |
2014-02-13 |
노파르티스 아게 |
암을 치료하기 위한 치료제의 조합물
|
|
JP2009535333A
(ja)
|
2006-04-26 |
2009-10-01 |
メルク エンド カムパニー インコーポレーテッド |
二置換アニリン化合物
|
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
|
GB0609378D0
(en)
|
2006-05-11 |
2006-06-21 |
Novartis Ag |
Organic compounds
|
|
US7964728B2
(en)
|
2006-07-06 |
2011-06-21 |
Solvay Pharmaceuticals B.V. |
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
|
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
BRPI0714828A2
(pt)
|
2006-07-17 |
2013-04-09 |
Novartis Ag |
amidas de Ácido colÂnico
|
|
US8080252B2
(en)
|
2006-07-19 |
2011-12-20 |
The Cleveland Clinic Foundation |
Compounds and methods of modulating angiogenesis
|
|
AU2007276760B2
(en)
|
2006-07-24 |
2012-01-19 |
Tetralogic Pharmaceuticals Corporation |
Dimeric IAP antagonists
|
|
WO2008019376A2
(en)
|
2006-08-07 |
2008-02-14 |
Pdl Biopharma, Inc. |
Compositions and methods using anti-cs1 antibodies to treat multiple myeloma
|
|
CA2660836A1
(en)
|
2006-08-07 |
2008-02-21 |
Incyte Corporation |
Triazolotriazines as kinase inhibitors
|
|
CA2659425C
(en)
|
2006-08-17 |
2017-06-20 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
AU2007287819A1
(en)
|
2006-08-23 |
2008-02-28 |
Novartis Ag |
Amides as sphingomyeline inhibitors
|
|
US8222288B2
(en)
|
2006-08-30 |
2012-07-17 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of MDM2 and the uses thereof
|
|
CA2974246C
(en)
|
2006-09-01 |
2020-02-25 |
Senhwa Biosciences, Inc. |
Tricyclic heteroaryl compounds and their use as protein modulators
|
|
AU2007292387A1
(en)
|
2006-09-05 |
2008-03-13 |
Bipar Sciences, Inc. |
Treatment of cancer
|
|
US8084471B2
(en)
|
2006-09-05 |
2011-12-27 |
Yale University |
Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides
|
|
WO2008046107A2
(en)
|
2006-10-13 |
2008-04-17 |
The Regents Of The University Of California |
Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface
|
|
CN101541319B
(zh)
|
2006-10-31 |
2013-09-18 |
托莱多大学 |
Src和Src家族激酶的Na+/K+-ATP酶特异性肽抑制剂/激活剂
|
|
AU2007314341B2
(en)
|
2006-10-31 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
|
|
MX2009004700A
(es)
|
2006-11-06 |
2009-05-15 |
Supergen Inc |
Derivados de imidazo[1,2-b]piridazin y pirazolo[1,5-a] pirimidina y su uso como inhibidores de proteina cinasa.
|
|
US20120164075A1
(en)
|
2006-11-21 |
2012-06-28 |
Jina Pharmaceuticals, Inc. |
Endoxifen methods and compositions in the treatment of mammalian diseases
|
|
US20080125397A1
(en)
|
2006-11-28 |
2008-05-29 |
Telik, Inc. |
2 (SULFONYL)ETHYL N,N,N',N' tetrakis(2 chloroethyl)phosphorodia
|
|
US7655799B2
(en)
|
2006-11-29 |
2010-02-02 |
Telik, Inc. |
2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates
|
|
BRPI0720105A2
(pt)
|
2006-12-11 |
2014-10-07 |
Kempharm Inc |
Conjugados de aminoácido não padrões de anfetamina e processos para fabricação e uso dos mesmos
|
|
EP1932820A1
(en)
|
2006-12-14 |
2008-06-18 |
Bp Oil International Limited |
Process for manufacturing neohexene
|
|
WO2008079982A2
(en)
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Liposome composition for targeting egfr receptor
|
|
WO2008079973A2
(en)
|
2006-12-21 |
2008-07-03 |
Centocor, Inc. |
Egfr binding peptides and uses thereof
|
|
US7956216B2
(en)
|
2006-12-21 |
2011-06-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Alpha-helical mimetics
|
|
US20080293648A1
(en)
|
2007-01-05 |
2008-11-27 |
Saha Pharmaceuticals, Inc. |
Compositions and Methods for Cancer Treatment
|
|
JP2010517976A
(ja)
|
2007-02-06 |
2010-05-27 |
ノバルティス アーゲー |
Ｃｃｒ９活性の阻害剤としての１−ベンゼンスルホニル−１ｈ−インドール誘導体
|
|
EP2120900A2
(en)
|
2007-02-15 |
2009-11-25 |
Novartis AG |
Combination of lbh589 with other therapeutic agents for treating cancer
|
|
JP5383513B2
(ja)
|
2007-03-09 |
2014-01-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
化合物およびその標的に関連する組成物ならびに方法
|
|
US8501233B2
(en)
|
2007-03-13 |
2013-08-06 |
Wake Forest University |
Compositions and methods for treating cancer
|
|
DK2139484T3
(da)
|
2007-04-10 |
2013-10-21 |
Exelixis Inc |
Fremgangsmåder til behandling af cancer ved brug af pyridopyrimidinon-inhibitorer af PI3K-alfa
|
|
EA200901375A1
(ru)
|
2007-04-13 |
2010-04-30 |
Новартис Аг |
Производные пиридазина, пиридина и пирана в качестве агонистов рецептора gpbar1
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
US7838495B2
(en)
|
2007-04-27 |
2010-11-23 |
University Of Maryland, Baltimore |
Compositions and methods of use of EPB1, and ErbB3 binding protein
|
|
EP2152694A2
(en)
|
2007-05-02 |
2010-02-17 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
|
WO2008144506A1
(en)
|
2007-05-16 |
2008-11-27 |
University Of Maryland, Baltimore |
Apoptotic pathway targeting for the diagnosis and treatment of cancer
|
|
US8367078B2
(en)
|
2007-06-06 |
2013-02-05 |
University Of Florida Research Foundation, Inc. |
Kinase inhibitor compounds
|
|
US20110288023A1
(en)
|
2007-06-08 |
2011-11-24 |
The Regents Of The University Of California Office Of Technology Transfer |
Cancer drug delivery using modified transferrin
|
|
US8273890B2
(en)
|
2007-06-29 |
2012-09-25 |
4Sc Ag |
Thiophene-imidazopyridines
|
|
US20090274698A1
(en)
|
2007-07-06 |
2009-11-05 |
Shripad Bhagwat |
Combination anti-cancer therapy
|
|
CN102006886A
(zh)
|
2007-08-03 |
2011-04-06 |
菲赛特生物技术公司 |
抗-tweak受体抗体的治疗用途
|
|
CA2736563C
(en)
|
2007-09-10 |
2016-01-26 |
Boston Biomedical, Inc. |
A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
|
|
US20100311678A1
(en)
|
2007-10-04 |
2010-12-09 |
Bean Bruce P |
Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways
|
|
DK2211904T3
(en)
|
2007-10-19 |
2016-10-24 |
Seattle Genetics Inc |
Cd19-binding agents and uses thereof
|
|
AU2008317406B2
(en)
|
2007-10-25 |
2013-07-18 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
|
JP5489235B2
(ja)
|
2007-11-15 |
2014-05-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
Ｎ含有複素環式化合物
|
|
MX2010005070A
(es)
|
2007-11-15 |
2010-05-24 |
Angeletti P Ist Richerche Bio |
Derivados de piridazinona como inhibidores de parp.
|
|
US8309718B2
(en)
|
2007-11-16 |
2012-11-13 |
Incyte Corporation |
4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
|
|
CN101444490A
(zh)
|
2007-11-26 |
2009-06-03 |
天津市金圭谷木糖醇有限公司 |
一种含脱水卫矛醇经注射给药的制剂及其制备方法
|
|
CN101450100A
(zh)
|
2007-11-28 |
2009-06-10 |
天津金世制药有限公司 |
一种治疗急慢性粒细胞白血病的药物组合物
|
|
WO2009076629A2
(en)
|
2007-12-12 |
2009-06-18 |
The Regents Of The University Of Michigan |
Compositions and methods for treating cancer
|
|
JP2011507880A
(ja)
|
2007-12-21 |
2011-03-10 |
ノバルティス アーゲー |
慢性リンパ性白血病の処置のためのニロチニブとナイトロジェンマスタードの組み合わせ剤
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
CN104474529A
(zh)
*
|
2008-02-08 |
2015-04-01 |
爱勒让治疗公司 |
治疗性的拟肽大环化合物
|
|
US20090202540A1
(en)
|
2008-02-11 |
2009-08-13 |
Auspex Pharmaceuticals, Inc. |
Substituted oxazaphosphorines
|
|
US20090209340A1
(en)
|
2008-02-14 |
2009-08-20 |
Aruze Gaming America, Inc. |
Gaming Apparatus Capable of Conversation with Player and Control Method Thereof
|
|
EP2259791A2
(en)
|
2008-03-05 |
2010-12-15 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
|
|
NZ587928A
(en)
|
2008-03-11 |
2012-08-31 |
Incyte Corp |
Azetidine and cyclobutane derivatives as jak inhibitors
|
|
EP2110377A1
(en)
|
2008-04-15 |
2009-10-21 |
DAC S.r.l. |
Spirocyclic derivatives as histone deacetylase inhibitors
|
|
RU2503687C2
(ru)
|
2008-04-30 |
2014-01-10 |
Иммьюноджен, Инк. |
Сшивающие реагенты и их применение
|
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
CA2726317A1
(en)
|
2008-06-03 |
2009-12-10 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
|
GB2475183B
(en)
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
EP2133334A1
(en)
|
2008-06-09 |
2009-12-16 |
DAC S.r.l. |
Heterocyclic derivatives as HDAC inhibitors
|
|
WO2010008744A2
(en)
*
|
2008-06-17 |
2010-01-21 |
Wyeth |
Antineoplastic combinations containing hki-272 and vinorelbine
|
|
US8207195B2
(en)
|
2008-06-26 |
2012-06-26 |
Inspire Pharmaceuticals, Inc. |
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
|
|
CN104042611B
(zh)
|
2008-07-08 |
2019-05-14 |
因塞特控股公司 |
作为吲哚胺2，3-双加氧酶的抑制剂的1，2，5-噁二唑
|
|
US8217076B2
(en)
|
2008-07-17 |
2012-07-10 |
Colorado State University Research Foundation |
Method for preparing largazole analogs and uses thereof
|
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
WO2010014755A1
(en)
|
2008-07-29 |
2010-02-04 |
The Regents Of The University Of Colorado |
Methods and compounds for enhancing anti-cancer therapy
|
|
WO2010021822A2
(en)
|
2008-07-30 |
2010-02-25 |
The Regents Of The University Of California |
Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
|
|
PT2313111E
(pt)
|
2008-08-01 |
2013-12-05 |
Ventirx Pharmaceuticals Inc |
Formulações de agonista de receptor do tipo toll e seus usos
|
|
AU2009286734A1
(en)
|
2008-08-26 |
2010-03-04 |
Boehringer Ingelheim International Gmbh |
Thienopyrimidines for pharmaceutical compositions
|
|
US20100068302A1
(en)
|
2008-09-17 |
2010-03-18 |
Traslational Cancer Drugs Pharma, S.L. |
Methods and compositions for the treatment of cancer
|
|
US8476282B2
(en)
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
|
US20100111901A1
(en)
|
2008-11-03 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Triazole inhibitors of aromatase
|
|
KR101805754B1
(ko)
|
2008-12-08 |
2017-12-07 |
먼디파머 인터내셔널 코포레이션 리미티드 |
단백질 수용체 티로신 키나아제 억제제의 조성물
|
|
WO2010068920A2
(en)
|
2008-12-12 |
2010-06-17 |
Auspex Pharmaceutical, Inc. |
Diaminoquinazoline inhibitors of dihydrofolate reductase
|
|
PA8851101A1
(es)
|
2008-12-16 |
2010-07-27 |
Lilly Co Eli |
Compuesto amino pirazol
|
|
US20110318430A1
(en)
|
2008-12-18 |
2011-12-29 |
New York University |
Tumor therapy with antitumor agents in combination with sindbis virus-based vectors
|
|
US20100173013A1
(en)
|
2009-01-08 |
2010-07-08 |
Denis Drygin |
Treatment of neoplastic disorders using combination therapies
|
|
AU2010210636A1
(en)
*
|
2009-02-04 |
2011-09-22 |
Bipar Sciences, Inc. |
Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitor
|
|
EP3620154A1
(en)
|
2009-02-06 |
2020-03-11 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
|
RU2011141123A
(ru)
|
2009-03-11 |
2013-04-20 |
Плексксикон, Инк. |
ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-b]ПИРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ RAF-КИНАЗ
|
|
EA201171195A8
(ru)
|
2009-03-30 |
2014-08-29 |
Серулин Фарма Инк. |
Конъюгаты, частицы, композиции "полимер-агент" и способы их применения
|
|
US8574829B2
(en)
|
2009-03-31 |
2013-11-05 |
The Trustees Of The University Of Pennsylvania |
Methods of treating cancer with phenformin
|
|
US8680139B2
(en)
|
2009-04-01 |
2014-03-25 |
Progenra |
Anti-neoplastic compounds, compositions and methods
|
|
CN102448951B
(zh)
|
2009-04-06 |
2017-05-10 |
安吉奥斯医药品有限公司 |
丙酮酸激酶m2调节剂、治疗组合物和相关使用方法
|
|
US20100291025A1
(en)
|
2009-04-13 |
2010-11-18 |
Auspex Pharmaceuticals, Inc. |
Indazole inhibitors of tyrosine kinase
|
|
US20110053968A1
(en)
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
|
US9151762B2
(en)
|
2009-06-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes
|
|
US8232318B2
(en)
|
2009-07-31 |
2012-07-31 |
The General Hospital Corporation |
Approaches to treat cancer using HB-EGF inhibitors
|
|
JP2013503183A
(ja)
|
2009-08-28 |
2013-01-31 |
武田薬品工業株式会社 |
ｍＴＯＲ阻害剤として使用するヘキサヒドロオキサジノプテリン化合物
|
|
AU2010292116A1
(en)
|
2009-09-11 |
2012-05-03 |
Cylene Pharmaceuticals Inc. |
Pharmaceutically useful heterocycle-substituted lactams
|
|
IN2012DN03217A
(cg-RX-API-DMAC7.html)
|
2009-09-16 |
2015-10-23 |
Cylene Pharmaceuticals Inc |
|
|
BR112012006807A2
(pt)
|
2009-09-28 |
2020-11-03 |
F.Hoffmann-La Roche Ag |
compostos da fórmula i, composição farmacêutica, composta por composto, método de tratamento de câncer em um mamífero, uso de um composto, kit para tratar um condição mediada por pi3k e processo para a preparação de um composto
|
|
US8304577B2
(en)
|
2009-10-09 |
2012-11-06 |
Bristol-Myers Squibb Company |
Modulators of G protein-coupled receptor 88
|
|
EP2488028B1
(en)
*
|
2009-10-14 |
2020-08-19 |
Merck Sharp & Dohme Corp. |
Substituted piperidines that increase p53 activity and the uses thereof
|
|
MY173390A
(en)
|
2009-10-23 |
2020-01-22 |
Takeda Pharmaceuticals Co |
Anti-gcc antibody molecules and related compositions and methods
|
|
PL2509602T3
(pl)
|
2009-12-04 |
2017-08-31 |
Senhwa Biosciences, Inc. |
Pirazolopirymidyny i podobne heterocykle jako inhibitory ck2
|
|
US8445517B2
(en)
|
2009-12-11 |
2013-05-21 |
Dana-Farber Cancer Institute |
Stat modulators
|
|
US20110195066A1
(en)
|
2010-02-05 |
2011-08-11 |
Auspex Pharmaceuticals, Inc. |
Quinoline inhibitors of tyrosine kinase
|
|
EP2539347A2
(en)
|
2010-02-24 |
2013-01-02 |
Auspex Pharmaceuticals, Inc. |
Trimethoxyphenyl inhibitors of tyrosine kinase
|
|
US8853193B2
(en)
|
2010-02-26 |
2014-10-07 |
Boehringer Ingelheim International Gmbh |
Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
|
|
UY33241A
(es)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
|
|
CN103002742B
(zh)
|
2010-03-05 |
2016-07-13 |
卡尔约药物治疗公司 |
核转运调节剂及其应用
|
|
US8389525B2
(en)
|
2010-05-05 |
2013-03-05 |
Renee Desai |
Small molecules for inhibition of protein kinases
|
|
AU2011253021A1
(en)
|
2010-05-12 |
2012-11-29 |
Vertex Pharmaceuticals Incorporated |
2 -aminopyridine derivatives useful as inhibitors of ATR kinase
|
|
RU2012154025A
(ru)
*
|
2010-05-14 |
2014-06-20 |
Дженентек, Инк. |
Способы лечения
|
|
WO2012018868A1
(en)
*
|
2010-08-02 |
2012-02-09 |
University Of Central Florida Research Foundation, Inc. |
Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat proteins
|
|
WO2012024367A2
(en)
*
|
2010-08-18 |
2012-02-23 |
Del Mar Pharmaceuticals |
Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
|
|
US9029103B2
(en)
*
|
2010-08-27 |
2015-05-12 |
Illumina Cambridge Limited |
Methods for sequencing polynucleotides
|
|
WO2012044832A1
(en)
|
2010-09-30 |
2012-04-05 |
Fetzer Oliver S |
Methods of treating a subject and related particles, polymers and compositions
|
|
CN103298474B
(zh)
|
2010-11-10 |
2016-06-29 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
SG182016A1
(en)
*
|
2010-12-14 |
2012-07-30 |
Univ Singapore |
Method of detecting resistance to cancer therapy
|
|
US20150087687A1
(en)
*
|
2012-03-23 |
2015-03-26 |
Dennis Brown |
Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
|
|
WO2013169600A1
(en)
*
|
2012-05-09 |
2013-11-14 |
Delmar Pharmaceuticals |
Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
|
|
US8729286B2
(en)
*
|
2012-05-10 |
2014-05-20 |
Massachusetts Institute Of Technology |
Platinum compounds as treatment for cancers, and related methods, kits, and compositions
|